跳至主要内容
临床试验/NCT01538602
NCT01538602已完成不适用

Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS)

AGUNCO Obstetrics and Gynecology Centre1 个研究点 分布在 1 个国家开始时间: 2012年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
试验地点
1
主要终点
Mean platelet volume

研究概览

简要总结

Polycystic ovary syndrome (PCOS)is closely associated with insulin resistance and hyperinsulinemia as well as with increased incidence in diabetes, hypertension, dyslipidemia and atherosclerosis. Indeed, subjects with PCOS were reported to carry an increased long-term cardiovascular risk, among others. Aiming to correlate the mean platelet volume, the thromboxane A2 level and the PCOS, an observational study was planned. Clinical evaluation of metabolic outcomes in PCOS patients is compared to a placebo group.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women fulfilled two out of three diagnostic criteria for PCOS

排除标准

  • Pre-existing secondary endocrine disorders
  • History of hypertension, diabetes mellitus or cardiovascular disorders
  • Pharmacologic treatment in the last 6 months before entering the study.

结局指标

主要结局

Mean platelet volume

Thromboxane A2

次要结局

未报告次要终点

研究者

发起方
AGUNCO Obstetrics and Gynecology Centre
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验